Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinoma (original) (raw)

• Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer. 2015;112(7):1141–56. doi:10.1038/bjc.2015.38.
  Article CAS PubMed PubMed Central Google Scholar
• Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: a comprehensive review. World J Hepatol. 2015;7(26):2648–63. doi:10.4254/wjh.v7.i26.2648.
  Article PubMed PubMed Central Google Scholar
• Rosa A, Ballarino M. Long Noncoding RNA Regulation of Pluripotency. Stem Cells Int. 2016;2016:1797692. doi:10.1155/2016/1797692.
  PubMed Google Scholar
• Briggs JA, Wolvetang EJ, Mattick JS, Rinn JL, Barry G. Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution. Neuron. 2015;88(5):861–77. doi:10.1016/j.neuron.2015.09.045.
  Article CAS PubMed Google Scholar
• Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell. 2014;26(3):344–57. doi:10.1016/j.ccr.2014.07.009.
  Article CAS PubMed PubMed Central Google Scholar
• Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25(5):666–81. doi:10.1016/j.ccr.2014.03.010.
  Article CAS PubMed Google Scholar
• Davidovich C, Cech TR. The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2. RNA. 2015;21(12):2007–22. doi:10.1261/rna.053918.115.
  Article CAS PubMed Google Scholar
• Silva A, Bullock M, Calin G. The clinical relevance of long non-coding RNAs in cancer. Cancers. 2015;7(4):2169–82. doi:10.3390/cancers7040884.
  Article PubMed PubMed Central Google Scholar
• Kim TK, Shiekhattar R. Architectural and functional commonalities between enhancers and promoters. Cell. 2015;162(5):948–59. doi:10.1016/j.cell.2015.08.008.
  Article CAS PubMed PubMed Central Google Scholar
• De Grassi A, Segala C, Iannelli F, Volorio S, Bertario L, Radice P et al. Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability. PLoS Biol. 2010;8(1):e1000275. doi:10.1371/journal.pbio.1000275.
  Article PubMed PubMed Central Google Scholar
• Peng JC, Shen J, Ran ZH. Transcribed ultraconserved region in human cancers. RNA Biol. 2013;10(12):1771–7. doi:10.4161/rna.26995.
  Article CAS PubMed PubMed Central Google Scholar
• Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA. 2011;108(2):786–91. doi:10.1073/pnas.1011098108.
  Article CAS PubMed Google Scholar
• Cao C, Sun J, Zhang D, Guo X, Xie L, Li X et al. The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterology. 2015;148(2):415–26. doi:10.1053/j.gastro.2014.10.012.
  Article CAS PubMed Google Scholar
• Zhang Y, Li Z, Zhang Y, Zhong Q, Chen Q, Zhang L. Molecular mechanism of HEIH and HULC in the proliferation and invasion of hepatoma cells. Int J Clin Exp Med. 2015;8(8):12956–62.
  PubMed PubMed Central Google Scholar
• Ehedego H, Boekschoten MV, Hu W, Doler C, Haybaeck J, Gabetaler N et al. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis. Cancer Res. 2015;75(6):1144–55. doi:10.1158/0008-5472.CAN-14-1356.
  Article CAS PubMed Google Scholar
• Deng W, Zhou Y, Tiwari AF, Su H, Yang J, Zhu D et al. p21/Cyclin E pathway modulates anticlastogenic function of Bmi-1 in cancer cells. Int J Cancer. 2015;136(6):1361–70. doi:10.1002/ijc.29114.
  Article CAS PubMed Google Scholar
• Rizki G, Boyer LA. Lncing epigenetic control of transcription to cardiovascular development and disease. Circulation Res. 2015;117(2):192–206. doi:10.1161/CIRCRESAHA.117.304156.
  Article CAS PubMed Google Scholar
• Kindrat I, Tryndyak V, de Conti A, Shpyleva S, Mudalige TK, Kobets T et al. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis. Oncotarget. 2015. doi:10.18632/oncotarget.6004.
  PubMed Central Google Scholar
• Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer. 2013;4(7–8):261–72. doi:10.1177/1947601913499020.
  Article CAS PubMed PubMed Central Google Scholar
• Guo W, Liu S, Cheng Y, Lu L, Shi J, Xu G et al. ICAM-1-related non-coding RNA in cancer stem cells maintains ICAM-1 expression in hepatocellular carcinoma. Clin Cancer Res. 2016. doi:10.1158/1078-0432.CCR-14-3106.
  Google Scholar
• Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer. 2013;12:13. doi:10.1186/1476-4598-12-13.
  Article CAS PubMed PubMed Central Google Scholar
• Satyanarayana A, Hilton MB, Kaldis P. p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol Biol Cell. 2008;19(1):65–77. doi:10.1091/mbc.E07-06-0525.
  Article CAS PubMed PubMed Central Google Scholar
• Bashir T, Pagano M. Cdk1: the dominant sibling of Cdk2. Nat Cell Biol. 2005;7(8):779–81. doi:10.1038/ncb0805-779.
  Article CAS PubMed Google Scholar
• Lee SH, Um SJ, Kim EJ. CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1. Cancer Lett. 2013;335(2):397–403. doi:10.1016/j.canlet.2013.02.051.
  Article CAS PubMed Google Scholar
• Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res. 2011;9(4):418–29. doi:10.1158/1541-7786.MCR-10-0511.
  Article CAS PubMed PubMed Central Google Scholar
• Balasubramanian S, Adhikary G, Eckert RL. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis. 2010;31(3):496–503. doi:10.1093/carcin/bgp314.
  Article CAS PubMed Google Scholar
• Liu K, Sun B, Zhao X, Wang X, Li Y, Qiu Z et al. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma. Int J Mol Med. 2015;36(3):783–91. doi:10.3892/ijmm.2015.2293.
  CAS PubMed Google Scholar
• Xu CR, Lee S, Ho C, Bommi P, Huang SA, Cheung ST et al. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis. Mol Cancer Res. 2009;7(12):1937–45. doi:10.1158/1541-7786.MCR-09-0333.
  Article CAS PubMed PubMed Central Google Scholar
• Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARFINK4a expression. Cancer Res. 2011;71(16):5365–9. doi:10.1158/0008-5472.CAN-10-4379.
  Article CAS PubMed PubMed Central Google Scholar